Menstrual and reproductive history and use of exogenous sex hormones and risk of thyroid cancer among women: a meta-analysis of prospective studies

Cancer Causes and Control

Volumn 26, Issue 4, 2015, Pages 511-518

  Caini, Saverio ^a   Gibelli, Bianca ^b   Palli, Domenico ^a   Saieva, Calogero ^a   Ruscica, Massimilano ^c   Gandini, Sara ^b  

^a ISPO Cancer Prevention and Research Institute   (Italy)

^b EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

Hormone use; Menstrual factors; Meta analysis; Reproductive factors; Thyroid cancer

Indexed keywords

CHORIONIC GONADOTROPIN; ENDOCRINE DISRUPTOR; ESTROGEN RECEPTOR; SEX HORMONE;

CANCER INCIDENCE; CANCER RISK; CARCINOGENESIS; CONTROLLED STUDY; FEMALE; HORMONE SUBSTITUTION; HUMAN; HYSTERECTOMY; MAJOR CLINICAL STUDY; MENOPAUSE; MENSTRUATION; META ANALYSIS; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; REPRODUCTIVE HISTORY; REVIEW; RISK FACTOR; SENSITIVITY ANALYSIS; THYROID CANCER; INCIDENCE; PHYSIOLOGY; PREGNANCY; REPRODUCTION; THYROID NEOPLASMS;

FEMALE; GONADAL STEROID HORMONES; HUMANS; INCIDENCE; MENOPAUSE; MENSTRUATION; PREGNANCY; REPRODUCTION; REPRODUCTIVE HISTORY; RISK FACTORS; THYROID NEOPLASMS;

EID: 84925467095     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-015-0546-z     Document Type: Review

References (56)

1. Kilfoy BA, Zheng T, Holford TR, Han X, Ward MH, Sjodin A, Zhang Y, Bai Y, Zhu C, Guo GL, Rothman N, Zhang Y (2009) International patterns and trends in thyroid cancer incidence, 1973–2002. Cancer Causes Control 20(5):525–531
2. Davies L, Welch HG (2014) Current thyroid cancer trends in the United States. JAMA Otolaryngol Head Neck Surg 140(4):317–322
3. Li N, Du XL, Reitzel LR, Xu L, Sturgis EM (2013) Impact of enhanced detection on the increase in thyroid cancer incidence in the United States: review of incidence trends by socioeconomic status within the surveillance, epidemiology, and end results registry, 1980–2008. Thyroid 23(1):103–110
4. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61(2):69–90
5. Rahbari R, Zhang L, Kebebew E (2010) Thyroid cancer gender disparity. Future Oncol 6(11):1771–1779
6. Zhao ZG, Guo XG, Ba CX, Wang W, Yang YY, Wang J, Cao HY (2012) Overweight, obesity and thyroid cancer risk: a meta-analysis of cohort studies. J Int Med Res 40(6):2041–2050
7. Bjoro T, Holmen J, Krüger O, Midthjell K, Hunstad K, Schreiner T, Sandnes L, Brochmann H (2000) Prevalence of thyroid disease, thyroid dysfunction and thyroid peroxidase antibodies in a large, unselected population. The Health Study of Nord-Trondelag (HUNT). Eur J Endocrinol 143(5):639–647
8. Vanderpump MP (2011) The epidemiology of thyroid disease. Br Med Bull 99:39–51
9. Balasubramaniam S, Ron E, Gridley G, Schneider AB, Brenner AV (2012) Association between benign thyroid and endocrine disorders and subsequent risk of thyroid cancer among 4.5 million U.S. male veterans. J Clin Endocrinol Metab 97(8):2661–2669
10. Fioretti F, Tavani A, Gallus S, Franceschi S, Negri E, La Vecchia C (1999) Case–control study of thyroid cancer in Northern Italy: attributable risk. Int J Epidemiol 28(4):626–630
11. Iribarren C, Haselkorn T, Tekawa IS, Friedman GD (2001) Cohort study of thyroid cancer in a San Francisco Bay area population. Int J Cancer 93(5):745–750
12. McTiernan AM, Weiss NS, Daling JR (1984) Incidence of thyroid cancer in women in relation to reproductive and hormonal factors. Am J Epidemiol 120(3):423–435
13. Manole D, Schildknecht B, Gosnell B, Adams E, Derwahl M (2001) Estrogen promotes growth of human thyroid tumor cells by different molecular mechanisms. J Clin Endocrinol Metab 86(3):1072–1077
14. Kumar A, Klinge CM, Goldstein RE (2010) Estradiol-induced proliferation of papillary and follicular thyroid cancer cells is mediated by estrogen receptors alpha and beta. Int J Oncol 36(5):1067–1080
15. Negri E, Dal Maso L, Ron E, La Vecchia C, Mark SD, Preston-Martin S, McTiernan A, Kolonel L, Yoshimoto Y, Jin F, Wingren G, Rosaria Galanti M et al (1999) A pooled analysis of case–control studies of thyroid cancer. II. Menstrual and reproductive factors. Cancer Causes Control 10(2):143–155
16. La Vecchia C, Ron E, Franceschi S, Dal Maso L, Mark SD, Chatenoud L, Braga C, Preston-Martin S, McTiernan A, Kolonel L, Mabuchi K, Jin F et al (1999) A pooled analysis of case–control studies of thyroid cancer. III. Oral contraceptives, menopausal replacement therapy and other female hormones. Cancer Causes Control 10(2):157–166
17. Wong EY, Ray R, Gao DL, Wernli KJ, Li W, Fitzgibbons ED, Feng Z, Thomas DB, Checkoway H (2006) Reproductive history, occupational exposures, and thyroid cancer risk among women textile workers in Shanghai, China. Int Arch Occup Environ Health 79(3):251–258
18. Pham TM, Fujino Y, Mikami H, Okamoto N, Hoshiyama Y, Tamakoshi A, Matsuda S, Yoshimura T (2009) Japan Collaborative Cohort Study group. reproductive and menstrual factors and thyroid cancer among Japanese women: the Japan Collaborative Cohort Study. J Womens Health (Larchmt) 18(3):331–335
19. Horn-Ross PL, Canchola AJ, Ma H, Reynolds P, Bernstein L (2011) Hormonal factors and the risk of papillary thyroid cancer in the California Teachers Study cohort. Cancer Epidemiol Biomarkers Prev 20(8):1751–1759
20. Kabat GC, Kim MY, Wactawski-Wende J, Lane D, Wassertheil-Smoller S, Rohan TE (2012) Menstrual and reproductive factors, exogenous hormone use, and risk of thyroid carcinoma in postmenopausal women. Cancer Causes Control 23(12):2031–2040
21. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D et al (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA 283(15):2008–2012
22. Meinhold CL, Ron E, Schonfeld SJ, Alexander BH, Freedman DM, Linet MS (2010) Berrington de González A. Nonradiation risk factors for thyroid cancer in the US Radiologic Technologists Study. Am J Epidemiol 171(2):242–252
23. Greenland S (1987) Quantitative methods in the review of epidemiologic literature. Epidemiol Rev 9:1–30
24. van Houwelingen HC, Arends LR, Stijnen T (2002) Advanced methods in meta-analysis: multivariate approach and meta-regression. Stat Med 21(4):589–624
25. Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21(11):1539–1558
26. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC (2008) Vandenbroucke JP; STROBE Initiative. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol 61(4):344–349
27. Macaskill P, Walter SD, Irwig L (2001) A comparison of methods to detect publication bias in meta-analysis. Stat Med 20(4):641–654
28. Yli-Kuha AN, Gissler M, Klemetti R, Luoto R, Hemminki E (2012) Cancer morbidity in a cohort of 9175 Finnish women treated for infertility. Hum Reprod 27(4):1149–1155
29. Källén B, Finnström O, Lindam A, Nilsson E, Nygren KG, Olausson PO (2011) Malignancies among women who gave birth after in vitro fertilization. Hum Reprod 26(1):253–258
30. Zamora-Ros R, Rinaldi S, Biessy C, Tjønneland A, Halkjaer J, Fournier A, Boutron-Ruault MC, Mesrine S, Tikk K, Fortner RT, Boeing H, Förster J, et al. (2014) Reproductive and menstrual factors and risk of differentiated thyroid carcinoma: the EPIC study. Int J Cancer (Epub ahead of print)
31. Braganza MZ, Berrington de González A, Schonfeld SJ, Wentzensen N, Brenner AV, Kitahara CM (2014) Benign breast and gynecologic conditions, reproductive and hormonal factors, and risk of thyroid cancer. Cancer Prev Res (Phila) 7(4):418–425
32. Sungwalee W, Vatanasapt P, Kamsa-Ard S, Suwanrungruang K, Promthet S (2013) Reproductive risk factors for thyroid cancer: a prospective cohort study in Khon Kaen, Thailand. Asian Pac J Cancer Prev 14(9):5153–5155
33. Schonfeld SJ, Ron E, Kitahara CM, Brenner A, Park Y, Sigurdson AJ, Schatzkin A, de González AB (2011) Hormonal and reproductive factors and risk of postmenopausal thyroid cancer in the NIH-AARP diet and health study. Cancer Epidemiol 35(6):e85–e90
34. Dorjgochoo T, Shu XO, Li HL, Qian HZ, Yang G, Cai H, Gao YT, Zheng W (2009) Use of oral contraceptives, intrauterine devices and tubal sterilization and cancer risk in a large prospective study, from 1996 to 2006. Int J Cancer 124(10):2442–2449
35. Rosenblatt KA, Gao DL, Ray RM, Nelson ZC, Wernli KJ, Li W, Thomas DB (2009) Oral contraceptives and the risk of all cancers combined and site-specific cancers in Shanghai. Cancer Causes Control 20(1):27–34
36. Hannibal CG, Jensen A, Sharif H, Kjaer SK (2008) Risk of thyroid cancer after exposure to fertility drugs: results from a large Danish cohort study. Hum Reprod 23(2):451–456
37. Rosenblatt KA, Gao DL, Ray RM, Rowland MR, Nelson ZC, Wernli KJ, Li W, Thomas DB (2006) Induced abortions and the risk of all cancers combined and site-specific cancers in Shanghai. Cancer Causes Control 17(10):1275–1280
38. Althuis MD, Scoccia B, Lamb EJ, Moghissi KS, Westhoff CL, Mabie JE, Brinton LA (2005) Melanoma, thyroid, cervical, and colon cancer risk after use of fertility drugs. Am J Obstet Gynecol 193(3 Pt 1):668–674
39. Navarro Silvera SA, Miller AB, Rohan TE (2005) Risk factors for thyroid cancer: a prospective cohort study. Int J Cancer 116(3):433–438
40. Neale RE, Darlington S, Murphy MF, Silcocks PB, Purdie DM, Talbäck M (2005) The effects of twins, parity and age at first birth on cancer risk in Swedish women. Twin Res Hum Genet 8(2):156–162
41. Luoto R, Grenman S, Salonen S, Pukkala E (2003) Increased risk of thyroid cancer among women with hysterectomies. Am J Obstet Gynecol 188(1):45–48
42. Modan B, Ron E, Lerner-Geva L, Blumstein T, Menczer J, Rabinovici J, Oelsner G, Freedman L, Mashiach S, Lunenfeld B (1998) Cancer incidence in a cohort of infertile women. Am J Epidemiol 147(11):1038–1042
43. Luoto R, Auvinen A, Pukkala E, Hakama M (1997) Hysterectomy and subsequent risk of cancer. Int J Epidemiol 26(3):476–483
44. Persson I, Yuen J, Bergkvist L, Schairer C (1996) Cancer incidence and mortality in women receiving estrogen and estrogen-progestin replacement therapy–long-term follow-up of a Swedish cohort. Int J Cancer 67(3):327–332
45. Galanti MR, Lambe M, Ekbom A, Sparén P, Pettersson B (1995) Parity and risk of thyroid cancer: a nested case–control study of a nationwide Swedish cohort. Cancer Causes Control 6(1):37–44
46. Akslen LA, Nilssen S, Kvåle G (1992) Reproductive factors and risk of thyroid cancer. A prospective study of 63,090 women from Norway. Br J Cancer 65(5):772–774
47. Brinton LA, Melton LJ 3rd, Malkasian GD Jr, Bond A, Hoover R (1989) Cancer risk after evaluation for infertility. Am J Epidemiol 129(4):712–722
48. Santin AP, Furlanetto TW (2011) Role of estrogen in thyroid function and growth regulation. J Thyroid Res 2011:875125
49. Huang Y, Dong W, Li J, Zhang H, Shan Z, Teng W (2014) Differential expression patterns and clinical significance of estrogen receptor-α and β in papillary thyroid carcinoma. BMC Cancer 29(14):383
50. Fleury Y, Van Melle G, Woringer V, Gaillard RC, Portmann L (2001) Sex-dependent variations and timing of thyroid growth during puberty. J Clin Endocrinol Metab 86(2):750–754
51. Weber G, Vigone MC, Stroppa L, Chiumello G (2003) Thyroid function and puberty. J Pediatr Endocrinol Metab 16(Suppl 2):253–257
52. Grün JP, Meuris S, De Nayer P, Glinoer D (1997) The thyrotrophic role of human chorionic gonadotrophin (hCG) in the early stages of twin (versus single) pregnancies. Clin Endocrinol (Oxf) 46(6):719–725
53. Leux C, Guénel P (2010) Risk factors of thyroid tumors: role of environmental and occupational exposures to chemical pollutants. Rev Epidemiol Sante Publique 58(5):359–367
54. Kim MH, Park YR, Lim DJ, Yoon KH, Kang MI, Cha BY, Lee KW, Son HY (2010) The relationship between thyroid nodules and uterine fibroids. Endocr J 57(7):615–621
55. Pellegriti G, Frasca F, Regalbuto C, Squatrito S, Vigneri R (2013) Worldwide increasing incidence of thyroid cancer: update on epidemiology and risk factors. J Cancer Epidemiol 2013:965212
56. Dieringer P, Klass EM, Caine B, Smith-Gagen J (2015) Associations between body mass and papillary thyroid cancer stage and tumor size: a population-based study. J Cancer Res Clin Oncol 141(1):93–98